Vital Art and Science Announces a New US Patent for its mVT® Service for Age Related Macular Degeneration and Diabetic Retinopathy Patients

DALLAS--(BUSINESS WIRE)--Vital Art and Science, LLC (VAS) announced today that the US Patent Office has granted another patent covering the novel technology of the firm’s innovative new mVT Service. The mVT Service is a FDA-cleared prescription medical device that conveniently and accurately tracks changes caused by AMD and DR. Use of the device enables clinicians to catch disease progression early when it is most responsive to treatment. VAS continues to validate the uniqueness of its advanced

Full Story →